Transfection Technologies Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Transfection Technologies Market will show an 8.9% CAGR from 2024 to 2032, stimulated by the prevalence of genetic and chronic diseases and innovations in genetic engineering and gene therapy. A report by the National Institutes of Health (NIH) in 2024 highlighted that Global gene therapy market was valued at approximately $5.5 billion in 2023 and will grow at a growth rate of 20.5% through 2027.

Innovations in delivery systems, such as improved viral vectors and nanoparticles, are enhancing the effectiveness and precision of gene transfer. Additionally, the rising adoption of transfection techniques in drug development and personalized medicine is accelerating market expansion. Continued R and D efforts aimed at overcoming existing limitations and optimizing protocols are shaping the industry outlook.

The transfection technologies market is classified based on product, method, application, end-use, and region.

The equipment segment will grow at a notable rate through 2032, due to a growing focus on enhancing the efficiency and scalability of genetic research and therapy applications. As researchers and biopharmaceutical companies seek to improve precision in gene delivery and overcome challenges associated with traditional methods, there is a rising need for advanced and reliable equipment. This shift is driven by the necessity for high-throughput screening capabilities, automation to streamline processes, and improved reproducibility of results. Consequently, investments in state-of-the-art transfection equipment are becoming more prevalent as organizations aim to achieve higher accuracy and efficiency in their research and development efforts.

The biomedical research segment will hold a considerable share of the transfection technologies market by 2032, driving innovation and expanding the scope of genetic research. As biomedical research increasingly focuses on understanding complex genetic mechanisms and developing novel therapeutic approaches, the demand for advanced transfection technologies rises. This segment's growth is fueled by the need for precise gene manipulation and expression analysis to advance fields such as cancer research, regenerative medicine, and functional genomics. The integration of transfection technologies into biomedical research facilitates the discovery of new biomarkers and therapeutic targets, propelling the market forward as researchers seek cutting-edge solutions to accelerate their findings and clinical applications.

Europe transfection technologies market will grow at a remarkable pace over the study period, driven by the strong emphasis on R and D in biotechnology and pharmaceuticals. Increased funding for life sciences research and favorable government policies are supporting innovation in gene therapy and molecular biology. Additionally, the presence of leading academic and research institutions in Europe, coupled with a growing number of biotechnology startups, contributes to the demand for advanced transfection technologies. Collaborative research efforts and partnerships between public and private sectors further stimulate market expansion.

Product Code: 9113

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic diseases
  - 3.2.1.2 Rise in research and development in the field of cell-based therapies
  - 3.2.1.3 Technological advancement
  - 3.2.1.4 Expanded applications of transfection technologies
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of transfection technology instruments
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Kits and reagents
5.3 Equipment

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Physical transfection
- 6.2.1 Electroporation
- 6.2.2 Biolistic transfection/ gene guns
- 6.2.3 Microinjection
- 6.2.4 Other physical transfection methods
6.3 Biochemical-based transfection
- 6.3.1 Lipofection
- 6.3.2 Calcium phosphate transfection
- 6.3.3 Cationic polymer transfection
- 6.3.4 DEAE-dextran transfection
- 6.3.5 Magnet-assisted transfection
- 6.3.6 Dendrimer-mediated transfection
6.4 Viral-vector based transfection
6.5 Cotransfection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Therapeutic delivery
- 7.2.1 Biotherapeutics
- 7.2.2 Electroimmunotherapy
- 7.2.3 Electrochemotherapy
7.3 Biomedical research
- 7.3.1 Gene and protein expression studies
- 7.3.2 Cancer research
- 7.3.3 Transgenic models
7.4 Protein production
7.5 Cell-based microarrays

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 CROs and CDMOs
8.4 Academic and research institutes
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Agilent Technologies, Inc.
10.2 Bio-Rad Laboratories, Inc.
10.3 Danaher Corporation
10.4 F. Hoffmann-La Roche Ltd
10.5 Lonza
10.6 MaxCyte, Inc.
10.7 QIAGEN N.V.
10.8 Revvity, Inc.
10.9 Sartorius AG
10.10 Thermo Fisher Scientific, Inc.